218 related articles for article (PubMed ID: 30832661)
1. Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma.
Zhuo H; Zhao Y; Cheng X; Xu M; Wang L; Lin L; Lyu Z; Hong X; Cai J
Mol Cancer; 2019 Mar; 18(1):34. PubMed ID: 30832661
[TBL] [Abstract][Full Text] [Related]
2. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
[TBL] [Abstract][Full Text] [Related]
3. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
[TBL] [Abstract][Full Text] [Related]
5. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
Pajares MJ; Agorreta J; Larrayoz M; Vesin A; Ezponda T; Zudaire I; Torre W; Lozano MD; Brambilla E; Brambilla C; Wistuba II; Behrens C; Timsit JF; Pio R; Field JK; Montuenga LM
J Clin Oncol; 2012 Apr; 30(10):1129-36. PubMed ID: 22355056
[TBL] [Abstract][Full Text] [Related]
6. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
[TBL] [Abstract][Full Text] [Related]
8. Effect of lung squamous cell carcinoma tumor microenvironment on the CD105+ endothelial cell proteome.
Zhuo H; Lyu Z; Su J; He J; Pei Y; Cheng X; Zhou N; Lu X; Zhou S; Zhao Y
J Proteome Res; 2014 Nov; 13(11):4717-29. PubMed ID: 25238122
[TBL] [Abstract][Full Text] [Related]
9. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cells and angiogenesis intensity in lung cancer.
Juczewska M; Chyczewska E; Naumnik W; Chyczewski L; Niklińska W; Rogalewska A; Kovalchuk O; Nikliński J
Folia Histochem Cytobiol; 2001; 39(3):253-8. PubMed ID: 11534781
[TBL] [Abstract][Full Text] [Related]
11. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
12. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B
J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
[TBL] [Abstract][Full Text] [Related]
14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
15. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY
Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466
[TBL] [Abstract][Full Text] [Related]
16. CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
Maishi N; Ohga N; Hida Y; Akiyama K; Kitayama K; Osawa T; Onodera Y; Shinohara N; Nonomura K; Shindoh M; Hida K
Pathol Int; 2012 May; 62(5):309-17. PubMed ID: 22524658
[TBL] [Abstract][Full Text] [Related]
17. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.
Agrawal V; Maharjan S; Kim K; Kim NJ; Son J; Lee K; Choi HJ; Rho SS; Ahn S; Won MH; Ha SJ; Koh GY; Kim YM; Suh YG; Kwon YG
Oncotarget; 2014 May; 5(9):2761-77. PubMed ID: 24811731
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic switching in the alveolar capillaries in primary lung adenocarcinoma and squamous cell carcinoma.
Morishita C; Jin E; Kikuchi M; Egawa S; Fujiwara M; Ohaki Y; Ghazizadeh M; Takemura T; Kawanami O
J Nippon Med Sch; 2007 Oct; 74(5):344-54. PubMed ID: 17965528
[TBL] [Abstract][Full Text] [Related]
19. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
20. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
